(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
Live Chart Being Loaded With Signals
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa...
Stats | |
---|---|
Today's Volume | 1.05M |
Average Volume | 654 693 |
Market Cap | 1.99B |
EPS | HKD0 ( 2024-03-21 ) |
Next earnings date | ( HKD0 ) 2024-06-27 |
Last Dividend | HKD0.173 ( 2023-08-24 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 8.00 |
ATR14 | HKD0.0190 (0.45%) |
Volume Correlation
Sisram Medical Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sisram Medical Ltd Correlation - Currency/Commodity
Sisram Medical Ltd Financials
Annual | 2023 |
Revenue: | HKD359.29M |
Gross Profit: | HKD219.53M (61.10 %) |
EPS: | HKD0.0674 |
FY | 2023 |
Revenue: | HKD359.29M |
Gross Profit: | HKD219.53M (61.10 %) |
EPS: | HKD0.0674 |
FY | 2022 |
Revenue: | HKD354.48M |
Gross Profit: | HKD202.23M (57.05 %) |
EPS: | HKD0.0862 |
FY | 2021 |
Revenue: | HKD294.29M |
Gross Profit: | HKD166.86M (56.70 %) |
EPS: | HKD0.0710 |
Financial Reports:
No articles found.
Sisram Medical Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.157 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.173 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.100 | 2019-06-21 |
Last Dividend | HKD0.173 | 2023-08-24 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | HKD0.610 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.82 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.82 | |
Div. Directional Score | 7.57 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
1978.HK | Ex Dividend Knight | 2023-09-14 | Annually | 0 | 0.00% | |
1001.HK | Ex Dividend Junior | 2023-08-24 | Annually | 0 | 0.00% | |
0101.HK | Ex Dividend Junior | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
3382.HK | Ex Dividend Junior | 2023-06-19 | Annually | 0 | 0.00% | |
1579.HK | Ex Dividend Knight | 2023-05-22 | Annually | 0 | 0.00% | |
0604.HK | Ex Dividend Junior | 2023-06-02 | Semi-Annually | 0 | 0.00% | |
9922.HK | Ex Dividend Knight | 2023-06-07 | Annually | 0 | 0.00% | |
2166.HK | Ex Dividend Knight | 2023-06-05 | Semi-Annually | 0 | 0.00% | |
1157.HK | Ex Dividend Junior | 2023-07-03 | Annually | 0 | 0.00% | |
0207.HK | Ex Dividend Junior | 2023-06-12 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0877 | 1.500 | 8.25 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0513 | 1.200 | 8.29 | 9.95 | [0 - 0.3] |
returnOnEquityTTM | 0.0706 | 1.500 | -0.327 | -0.490 | [0.1 - 1] |
payoutRatioTTM | 0.334 | -1.000 | 6.66 | -6.66 | [0 - 1] |
currentRatioTTM | 2.92 | 0.800 | 0.419 | 0.335 | [1 - 3] |
quickRatioTTM | 1.925 | 0.800 | 3.38 | 2.71 | [0.8 - 2.5] |
cashRatioTTM | 0.800 | 1.500 | 6.67 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0728 | -1.500 | 8.79 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0940 | 2.00 | 9.97 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0757 | 2.00 | 9.96 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0988 | -1.500 | 9.60 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.611 | 1.000 | 3.15 | 3.15 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.106 | 1.000 | 9.88 | 9.88 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.983 | 1.000 | 5.65 | 5.65 | [0.2 - 2] |
assetTurnoverTTM | 0.586 | 0.800 | 9.43 | 7.54 | [0.5 - 2] |
Total Score | 10.33 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.05 | 1.000 | 9.29 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0706 | 2.50 | -0.210 | -0.490 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0757 | 2.00 | 9.97 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 31.88 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0940 | 2.00 | 9.97 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.334 | 1.500 | 6.66 | -6.66 | [0 - 1] |
pegRatioTTM | -1.760 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.122 | 1.000 | 9.44 | 0 | [0.1 - 0.5] |
Total Score | 4.82 |
Sisram Medical Ltd
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectables, personal care, aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company manufactures, distributes, and sells medical equipment. It offers its products under the Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT brands. Sisram Medical Ltd was incorporated in 2013 and is headquartered in Caesarea, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators